102
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Positive Response to Methylprednisolone in a Child with Reactive Lymphoid Hyperplasia of the Conjunctiva

&
Pages 446-449 | Accepted 08 Dec 2013, Published online: 07 Feb 2014
 

Abstract

The aim of this paper is to present the case of a child with reactive lymphoid hyperplasia of the conjunctiva, whose lesion regressed completely after oral glucocorticosteroid treatment. The final diagnosis was established on the basis of a histopathological examination combined with an immunohistochemical staining test and the exclusion of other conditions that could generate similar lesions. Because of the lack of general contraindications, methylprednisolone treatment was administered and local improvement was obtained. Reactive lymphoid hyperplasia of the conjunctiva is rarely found in children. It is important to emphasize the fact that lymphoproliferative lesions in the conjunctiva may, on the one hand, represent a lymphoma; on the other hand, they may be caused by a benign lesion—reactive lymphoid hyperplasia of the conjunctiva. Many treatment methods have been reported in the literature on the subject, but there are no clear guidelines concerning therapy in children.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.